calcium acetate 133 MG/ML Oral Solution [Phoslyra]
RxNorm concept 1099808, branded drug (sbd). Prescribable name: Phoslyra 667 MG in 5 mL Oral Solution.
- RxCUI
- 1099808
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1099808 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Phoslyra 133 MG/ML Oral Solution; Phoslyra 667 MG per 5 ML Oral Solution
Related concepts
- calcium acetate 133 MG/ML (SCDC, consists of)
- calcium acetate 133 MG/ML [Phoslyra] (SBDC, consists of)
- Oral Solution (DF, has dose form)
- Phoslyra (BN, has ingredient)
- calcium acetate 133 MG/ML Oral Solution (SCD, tradename of)
Linked data
NDCs
- 49230064331
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1099808 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1099808 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1099808. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.